- Report
- May 2024
- 134 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- April 2024
- 140 Pages
Global
From €4746EUR$4,969USD£3,969GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1910EUR$2,000USD£1,597GBP
- Report
- October 2024
- 196 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- October 2024
- 188 Pages
Global
From €2388EUR$2,500USD£1,997GBP
- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Drug Pipelines
- June 2024
- 60 Pages
Global
From €1194EUR$1,250USD£998GBP
- Report
- January 2022
- 148 Pages
Global
From €4059EUR$4,250USD£3,394GBP
- Report
- January 2022
- 278 Pages
Global
From €4059EUR$4,250USD£3,394GBP
- Report
- April 2023
- 450 Pages
Global
From €3811EUR$3,990USD£3,187GBP
- Report
- October 2021
- 112 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- January 2022
- 200 Pages
Global
From €7163EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3772EUR$3,950USD£3,155GBP
- Report
- October 2024
- 97 Pages
Global
From €3500EUR$3,926USD£3,029GBP
- Report
- September 2022
- 133 Pages
Global
From €1910EUR$2,000USD£1,597GBP

Cancer pain is a common symptom of cancer and its treatments. It is caused by the tumor pressing on nerves, bones, or organs, or by the side effects of chemotherapy, radiation, or surgery. It can range from mild to severe and can be managed with medications, physical therapy, and other treatments.
Oncology drugs are used to treat cancer and its symptoms, including cancer pain. These drugs can be divided into two categories: analgesics, which are used to reduce pain, and adjuvant drugs, which are used to reduce the side effects of cancer treatments. Analgesics include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants. Adjuvant drugs include corticosteroids, antidepressants, and antispasmodics.
The cancer pain market is a rapidly growing segment of the oncology drugs market. It is driven by the increasing prevalence of cancer, the development of new drugs, and the increasing demand for pain relief.
Some companies in the cancer pain market include Pfizer, Novartis, Merck, and Johnson & Johnson. Show Less Read more